Dr. Kimberly Cockerham Discusses New Findings in Chronic Thyroid Eye Disease Treatment
Learn more about the latest advancements in the treatment of Thyroid Eye Disease (TED) in this presentation by Dr. Kimberly Cockerham. She discusses the findings from the THRIVE-2 Phase 3 Veligrotug Trial, focusing on efficacy, safety, and quality of life outcomes at 15 weeks.


